MENEGATTI, MARZIA
MENEGATTI, MARZIA
Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti
Rare inherited coagulation disorders: no longer orphan and neglected
2024 S. Mohsenian, P.M. Mannucci, M. Menegatti, F. Peyvandi
Congenital fibrinogen disorders: a retrospective clinical and genetic analysis of the Prospective Rare Bleeding Disorders Database
2024 S. Mohsenian, R. Palla, M. Menegatti, A. Cairo, A. Lecchi, A. Casini, M. Neerman-Arbez, R. Asselta, S. Scardo, S.M. Siboni, J. Blatny, O. Zapletal, J. Schved, M. Giansily-Blaizot, S. Halimeh, M.A. Daoud, H. Platokouki, H. Pergantou, R.E.G. Schutgens, M. Van Haaften-Spoor, P. Brons, B. Laros-van Gorkom, E. Van Pinxten, M. Borhany, N. Fatima, D. Mikovic, M. Saracevic, G.N. Özdemir, Y. Ay, M. Makris, C. Lockley, A. Mumford, A. Harvey, S. Austin, A. Shapiro, A. Williamson, C. Mcguinn, I. Goldberg, P. De Moerloose, F. Peyvandi
Clinical, Laboratory Aspects and Management of Factor X Deficiency
2024 M. Menegatti, F. Peyvandi
Diagnostic utility of bleeding assessment tools in congenital fibrinogen deficiencies
2023 S. Mohsenian, O. Seidizadeh, R. Palla, M. Jazebi, A. Azarkeivan, S. Moazezi, M.R. Baghaipour, M. Menegatti, F. Peyvandi
A homozygous duplication of the FGG exon 8-intron 8 junction causes congenital afibrinogenemia. Lessons learned from the study of a large consanguineous Turkish family
2021 M. Guipponi, F. Masclaux, F. Sloan-Béna, C. Di Sanza, N. Özbek, F. Peyvandi, M. Menegatti, A. Casini, B. Malbora, M. Neerman-Arbez
Rare variants lowering the levels of coagulation factor X are protective against ischemic heart disease
2020 E.M. Paraboschi, A.V. Khera, P.A. Merlini, L. Gigante, F. Peyvandi, M. Chaffin, M. Menegatti, F. Busti, D. Girelli, N. Martinelli, O. Olivieri, S. Kathiresan, D. Ardissino, R. Asselta, S. Duga
An international registry of patients with plasminogen deficiency (HISTORY)
2020 A.D. Shapiro, M. Menegatti, R. Palla, M. Boscarino, C. Roberson, P. Lanzi, J. Bowen, C. Nakar, I.A. Janson, F. Peyvandi
Analysis of factor V in zebrafish demonstrates minimal levels needed for early hemostasis
2019 A.C. Weyand, S.J. Grzegorski, M.S. Rost, K.I. Lavik, A.C. Ferguson, M. Menegatti, C.E. Richter, R. Asselta, S. Duga, F. Payvandi, J.A. Shavit
Understanding the Impact of Aberrant Splicing in Coagulation Factor V Deficiency.
2019 E. Paraboschi, M. Menegatti, F. Payvandi, S. Duga, R. Asselta
Treatment of rare factor deficiencies other than hemophilia
2019 M. Menegatti, F. Peyvandi
Molecular investigation of 41 patients affected by coagulation factor XI deficiency
2018 V. Rimoldi, E.M. Paraboschi, M. Menegatti, F. Peyvandi, O. Salomon, S. Duga, R. Asselta
Recombinant factor XIII A-subunit in a patient with factor XIII deficiency and recurrent pregnancy loss
2018 M. Al-Khabori, A. Pathare, M. Menegatti, F. Payvandi
Genome editing of factor X in zebrafish reveals unexpected tolerance of severe defects in the common pathway
2017 Z. Hu, Y. Liu, M.C. Huarng, M. Menegatti, D. Reyon, M.S. Rost, Z.G. Norris, C.E. Richter, A.N. Stapleton, N.C. Chi, F. Peyvandi, J.K. Joung, J.A. Shavit
Minimal factor XIII activity level to prevent major spontaneous bleeds : reply
2017 M. Menegatti, R. Palla, P. Bucciarelli, F. Peyvandi
Exploring the global landscape of genetic variation in coagulation factor XI deficiency
2017 R. Asselta, E.M. Paraboschi, V. Rimoldi, M. Menegatti, F. Peyvandi, O. Salomon, S. Duga
Detection of Factor XIII deficiency: data from multicentre exercises amongst UK NEQAS and PRO-RBDD project laboratories
2017 I. Jennings, S. Kitchen, M. Menegatti, R. Palla, I. Walker, M. Makris, F. Peyvandi
Potential misdiagnosis of dysfibrinogenaemia: Data from multicentre studies amongst UK NEQAS and PRO-RBDD project laboratories
2017 I. Jennings, S. Kitchen, M. Menegatti, R. Palla, I. Walker, F. Peyvandi, M. Makris
Treatment of rare factor deficiencies in 2016
2016 F. Peyvandi, M. Menegatti
Minimal residual FXIII coagulant activity to prevent spontaneous major bleeding, on behalf of the PRO-RBDD group
2016 F. Peyvandi, R. Palla, M. Menegatti, P. Bucciarelli, M. Boscarino, L. Muszbek
Reduced fibrinolytic resistance in patients with factor XI deficiency : Evidence of a thrombin-independent impairment of the thrombin-activatable fibrinolysis inhibitor pathway
2016 M. Colucci, F. Incampo, A. Cannavò, M. Menegatti, S.M. Siboni, F. Zaccaria, N. Semeraro, F. Peyvandi